Ashleigh Furlong
@ashleighfurlong.bsky.social
Health reporter at Bloomberg
Previously POLITICO and GroundUp News
Opinions my own
Previously POLITICO and GroundUp News
Opinions my own
Exclusive: Bloomberg takes you inside AstraZeneca, revealing a culture where mediocrity isn’t tolerated — and where CEO Pascal Soriot maintains pervasive oversight.
And we ask the question: Is Astra ready for a future without Soriot?
Gift link: www.bloomberg.com/news/feature...
And we ask the question: Is Astra ready for a future without Soriot?
Gift link: www.bloomberg.com/news/feature...
AstraZeneca’s CEO Is Willing to Compromise — When It’s for Trump
Pascal Soriot has turned the drugmaker into an oncology powerhouse with a high-pressure culture and a deep relationship with the US.
www.bloomberg.com
November 5, 2025 at 7:57 AM
Exclusive: Bloomberg takes you inside AstraZeneca, revealing a culture where mediocrity isn’t tolerated — and where CEO Pascal Soriot maintains pervasive oversight.
And we ask the question: Is Astra ready for a future without Soriot?
Gift link: www.bloomberg.com/news/feature...
And we ask the question: Is Astra ready for a future without Soriot?
Gift link: www.bloomberg.com/news/feature...
Reposted by Ashleigh Furlong
For decades, prostate cancer care has forced men into a cruel choice:
🪓 Remove the whole prostate, with life-altering side effects
🤷♂️ Or risk living with the disease
In London, surgeon Hashim Ahmed is betting on a 3rd way: focal therapy. My story with @ashleighfurlong.bsky.social
tinyurl.com/2rya36ds
🪓 Remove the whole prostate, with life-altering side effects
🤷♂️ Or risk living with the disease
In London, surgeon Hashim Ahmed is betting on a 3rd way: focal therapy. My story with @ashleighfurlong.bsky.social
tinyurl.com/2rya36ds
The Fight to Fix Prostate Cancer Care
For decades, men with the disease faced a binary choice: live with the cancer, or live with the consequences of removing it. This doctor is pushing an alternative that he says is more precise, humane ...
www.bloomberg.com
October 3, 2025 at 1:45 AM
For decades, prostate cancer care has forced men into a cruel choice:
🪓 Remove the whole prostate, with life-altering side effects
🤷♂️ Or risk living with the disease
In London, surgeon Hashim Ahmed is betting on a 3rd way: focal therapy. My story with @ashleighfurlong.bsky.social
tinyurl.com/2rya36ds
🪓 Remove the whole prostate, with life-altering side effects
🤷♂️ Or risk living with the disease
In London, surgeon Hashim Ahmed is betting on a 3rd way: focal therapy. My story with @ashleighfurlong.bsky.social
tinyurl.com/2rya36ds
For decades, men with prostate cancer faced a binary choice: live with the cancer, or live with the consequences of removing it. This doctor is pushing an alternative that he says is more precise, humane and effective.
Gift link to our Businessweek story: t.co/GXLf21gfox
Gift link to our Businessweek story: t.co/GXLf21gfox
https://www.bloomberg.com/news/articles/2025-10-02/focal-therapy-for-prostate-cancer-care-is-an-emerging-new-treatment?accessToken=eyJhbGciOiJIUzI1NiIsInR5cCI6IkpXVCJ9.eyJzb3VyY2UiOiJTdWJzY3JpYmVyR2lm...
t.co
October 2, 2025 at 10:46 AM
For decades, men with prostate cancer faced a binary choice: live with the cancer, or live with the consequences of removing it. This doctor is pushing an alternative that he says is more precise, humane and effective.
Gift link to our Businessweek story: t.co/GXLf21gfox
Gift link to our Businessweek story: t.co/GXLf21gfox
Scoop: J&J is withdrawing a device called Linx that treats acid reflux disease (GERD) from markets outside the US. Surgeons have described the news as devastating and said it will also impacting lung transplant patients.
Gift link to story: www.bloomberg.com/news/article...
Gift link to story: www.bloomberg.com/news/article...
J&J to Withdraw Acid Reflux Device Outside US, Alarming Surgeons
Johnson & Johnson is withdrawing a device to treat debilitating acid reflux disease from markets outside the US, a move surgeons warned would set back the available treatment options for sufferers...
www.bloomberg.com
September 23, 2025 at 9:49 AM
Scoop: J&J is withdrawing a device called Linx that treats acid reflux disease (GERD) from markets outside the US. Surgeons have described the news as devastating and said it will also impacting lung transplant patients.
Gift link to story: www.bloomberg.com/news/article...
Gift link to story: www.bloomberg.com/news/article...
UK patients on Mounjaro are desperately trying to figure out what they will do when the price rises in Sept. It's led to a surge in interest for Novo Nordisk's Wegovy.
It's not an easy decision and there's a bigger looming fear: What if Novo does the same as Lilly?
www.bloomberg.com/news/article...
It's not an easy decision and there's a bigger looming fear: What if Novo does the same as Lilly?
www.bloomberg.com/news/article...
Novo Obesity Shot Sees Interest Soar in UK as Rival Lifts Prices
Demand for Novo Nordisk A/S’s weight-loss blockbuster Wegovy is getting a boost in the UK from an unexpected corner: arch-rival Eli Lilly & Co.
www.bloomberg.com
August 21, 2025 at 8:19 AM
UK patients on Mounjaro are desperately trying to figure out what they will do when the price rises in Sept. It's led to a surge in interest for Novo Nordisk's Wegovy.
It's not an easy decision and there's a bigger looming fear: What if Novo does the same as Lilly?
www.bloomberg.com/news/article...
It's not an easy decision and there's a bigger looming fear: What if Novo does the same as Lilly?
www.bloomberg.com/news/article...
Powerful reporting from @groundup.org.za revealing how Trump's aid cuts have resulted in children dying in Mozambique.
groundup.org.za/article/moza...
groundup.org.za/article/moza...
Mozambique: These are the children the United States left to die
Part one: How the Trump Administration abandoned orphans with HIV
groundup.org.za
June 20, 2025 at 7:00 AM
Powerful reporting from @groundup.org.za revealing how Trump's aid cuts have resulted in children dying in Mozambique.
groundup.org.za/article/moza...
groundup.org.za/article/moza...
Reposted by Ashleigh Furlong
🚨 NEW TOOL ALERT: Meet NudgeDetect 🚨
Ever felt nudged into clicking "Buy Now", unknowingly subscribing, or paying hidden fees?
NudgeDetect is a Chrome extension I’ve built to reveal ‘manipulative’ website tricks: and help you fight back.
chromewebstore.google.com/detail/aodlb...
1/5
Ever felt nudged into clicking "Buy Now", unknowingly subscribing, or paying hidden fees?
NudgeDetect is a Chrome extension I’ve built to reveal ‘manipulative’ website tricks: and help you fight back.
chromewebstore.google.com/detail/aodlb...
1/5
May 19, 2025 at 7:13 AM
🚨 NEW TOOL ALERT: Meet NudgeDetect 🚨
Ever felt nudged into clicking "Buy Now", unknowingly subscribing, or paying hidden fees?
NudgeDetect is a Chrome extension I’ve built to reveal ‘manipulative’ website tricks: and help you fight back.
chromewebstore.google.com/detail/aodlb...
1/5
Ever felt nudged into clicking "Buy Now", unknowingly subscribing, or paying hidden fees?
NudgeDetect is a Chrome extension I’ve built to reveal ‘manipulative’ website tricks: and help you fight back.
chromewebstore.google.com/detail/aodlb...
1/5
The pharma industry is flocking to Spain. We wanted to know why.
The answer was fascinating: Tax breaks; cheap, good quality science and a government bending over backwards to attract investment.
Read the story here (gift link):
www.bloomberg.com/news/article...
The answer was fascinating: Tax breaks; cheap, good quality science and a government bending over backwards to attract investment.
Read the story here (gift link):
www.bloomberg.com/news/article...
How Spain Became Big Pharma’s New Hotspot in Europe
Spain ranks first in Europe for clinical trials and is attracting investment in life sciences, but faces intense competition including from China.
www.bloomberg.com
April 2, 2025 at 8:37 AM
The pharma industry is flocking to Spain. We wanted to know why.
The answer was fascinating: Tax breaks; cheap, good quality science and a government bending over backwards to attract investment.
Read the story here (gift link):
www.bloomberg.com/news/article...
The answer was fascinating: Tax breaks; cheap, good quality science and a government bending over backwards to attract investment.
Read the story here (gift link):
www.bloomberg.com/news/article...
SCOOP: GSK is pushing the UK government to give pharma companies more access to its public health data troves, to halt the nation’s slide down global life science rankings.
Revealed by FOI requests, we found out the gov is assessing the feasibility of the proposal. www.bloomberg.com/news/article...
Revealed by FOI requests, we found out the gov is assessing the feasibility of the proposal. www.bloomberg.com/news/article...
March 28, 2025 at 8:14 AM
SCOOP: GSK is pushing the UK government to give pharma companies more access to its public health data troves, to halt the nation’s slide down global life science rankings.
Revealed by FOI requests, we found out the gov is assessing the feasibility of the proposal. www.bloomberg.com/news/article...
Revealed by FOI requests, we found out the gov is assessing the feasibility of the proposal. www.bloomberg.com/news/article...
Gavi's CEO Sania Nishtar isn't accepting the Trump administration's plan to terminate its funding without a fight.
Bloomberg interviewed Nishtar as she heads to Washington, hoping to persuade US to reverse a decision that threatens millions of lives.
Gift link: www.bloomberg.com/news/article...
Bloomberg interviewed Nishtar as she heads to Washington, hoping to persuade US to reverse a decision that threatens millions of lives.
Gift link: www.bloomberg.com/news/article...
Blindsided by Trump, Vaccine Chief Fights to Reverse Funding Cut
The head of the global organization responsible for vaccinating children in the world’s poorest countries is headed to Washington, hoping to persuade the Trump administration to reverse a surprise dec...
www.bloomberg.com
March 28, 2025 at 8:07 AM
Gavi's CEO Sania Nishtar isn't accepting the Trump administration's plan to terminate its funding without a fight.
Bloomberg interviewed Nishtar as she heads to Washington, hoping to persuade US to reverse a decision that threatens millions of lives.
Gift link: www.bloomberg.com/news/article...
Bloomberg interviewed Nishtar as she heads to Washington, hoping to persuade US to reverse a decision that threatens millions of lives.
Gift link: www.bloomberg.com/news/article...
Reposted by Ashleigh Furlong
Scoop: "The World Health Organization is asking some employees to consider early retirement as the United Nations agency seeks to cut costs following US President Donald Trump’s decision to withdraw."
WHO Offers Early Retirement to Cut Costs Ahead of US Exit
The World Health Organization is asking some employees to consider early retirement as the United Nations agency seeks to cut costs following US President Donald Trump’s decision to withdraw.
www.bloomberg.com
March 7, 2025 at 12:49 PM
Scoop: "The World Health Organization is asking some employees to consider early retirement as the United Nations agency seeks to cut costs following US President Donald Trump’s decision to withdraw."
SCOOP: WHO is asking employees to consider early retirement as it seeks to cut costs following Trump’s decision to withdraw.
Staff aged 55 years old or older can retire with 4 months pay, according to copy of confidential email seen by Bloomberg.
Gift link: www.bloomberg.com/news/article...
Staff aged 55 years old or older can retire with 4 months pay, according to copy of confidential email seen by Bloomberg.
Gift link: www.bloomberg.com/news/article...
WHO Offers Early Retirement to Cut Costs Ahead of US Exit
The World Health Organization is asking some employees to consider early retirement as the United Nations agency seeks to cut costs following US President Donald Trump’s decision to withdraw.
www.bloomberg.com
March 7, 2025 at 12:40 PM
SCOOP: WHO is asking employees to consider early retirement as it seeks to cut costs following Trump’s decision to withdraw.
Staff aged 55 years old or older can retire with 4 months pay, according to copy of confidential email seen by Bloomberg.
Gift link: www.bloomberg.com/news/article...
Staff aged 55 years old or older can retire with 4 months pay, according to copy of confidential email seen by Bloomberg.
Gift link: www.bloomberg.com/news/article...
Trump's dramatic remaking of global health means more people will die from preventable conditions, according to scientists and other experts interviewed by Bloomberg.
“This is the worst scenario I can possibly imagine,” says virologist Angela Rasmussen.
www.bloomberg.com/news/article...
“This is the worst scenario I can possibly imagine,” says virologist Angela Rasmussen.
www.bloomberg.com/news/article...
The US Is Withdrawing From Global Health at a Dangerous Time
Trump’s overhaul of the CDC has scientists worried about flu, measles and even Ebola.
www.bloomberg.com
March 3, 2025 at 10:47 AM
Trump's dramatic remaking of global health means more people will die from preventable conditions, according to scientists and other experts interviewed by Bloomberg.
“This is the worst scenario I can possibly imagine,” says virologist Angela Rasmussen.
www.bloomberg.com/news/article...
“This is the worst scenario I can possibly imagine,” says virologist Angela Rasmussen.
www.bloomberg.com/news/article...
AI drug developer Recursion Pharmaceuticals Inc. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines.
We spoke with CEO Chris Gibson this week at the company's King's Cross office about the idea. Gift link:
www.bloomberg.com/news/article...
We spoke with CEO Chris Gibson this week at the company's King's Cross office about the idea. Gift link:
www.bloomberg.com/news/article...
AI Drug Firm Recursion Wants to Be the Amazon Prime of Pharma
AI drug developer Recursion Pharmaceuticals Inc. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines.
www.bloomberg.com
February 28, 2025 at 2:28 PM
AI drug developer Recursion Pharmaceuticals Inc. is considering an Amazon Prime-style subscription model for selling its pipeline of medicines.
We spoke with CEO Chris Gibson this week at the company's King's Cross office about the idea. Gift link:
www.bloomberg.com/news/article...
We spoke with CEO Chris Gibson this week at the company's King's Cross office about the idea. Gift link:
www.bloomberg.com/news/article...
Reliance on private hospitals by the NHS is helping patients get seen quicker than they otherwise would.
But it's also fueling a two-track system, benefitting those with less complex conditions.
Our big data story w/ @andretartar, @RachelLavin is out:
www.bloomberg.com/graphics/202...
But it's also fueling a two-track system, benefitting those with less complex conditions.
Our big data story w/ @andretartar, @RachelLavin is out:
www.bloomberg.com/graphics/202...
Private Hospitals Are Helping the NHS Cut Wait Times — With Trade Offs
As of December, more than 7.4 million cases were still on waiting lists.
www.bloomberg.com
February 27, 2025 at 10:59 AM
Reliance on private hospitals by the NHS is helping patients get seen quicker than they otherwise would.
But it's also fueling a two-track system, benefitting those with less complex conditions.
Our big data story w/ @andretartar, @RachelLavin is out:
www.bloomberg.com/graphics/202...
But it's also fueling a two-track system, benefitting those with less complex conditions.
Our big data story w/ @andretartar, @RachelLavin is out:
www.bloomberg.com/graphics/202...
Exclusive: Financing for global health has never looked more dire as the world reels from Trump’s dramatic pullback. Now the biggest funder of programs against HIV, tuberculosis and malaria is looking to the UK and others to urgently raise $18 billion.
Gift link: www.bloomberg.com/news/article...
Gift link: www.bloomberg.com/news/article...
Global Fund Seeks $18 Billion as US Retreats From Public Health
Financing for global health has never looked more dire as the world reels from US President Donald Donald Trump’s dramatic pullback. Now the biggest funder of programs against HIV, tuberculosis and ma...
www.bloomberg.com
February 18, 2025 at 3:29 PM
Exclusive: Financing for global health has never looked more dire as the world reels from Trump’s dramatic pullback. Now the biggest funder of programs against HIV, tuberculosis and malaria is looking to the UK and others to urgently raise $18 billion.
Gift link: www.bloomberg.com/news/article...
Gift link: www.bloomberg.com/news/article...
Reposted by Ashleigh Furlong
Very useful tracker of legal challenges to Trump's admin orders. @ashleighfurlong.bsky.social @publiccitizen.bsky.social
February 4, 2025 at 4:23 PM
Very useful tracker of legal challenges to Trump's admin orders. @ashleighfurlong.bsky.social @publiccitizen.bsky.social
The WHO is having to step in to fill gaps left by the US in the latest Ebola outbreak in Uganda, WHO emergencies chief Mike Ryan told Bloomberg.
It comes as WHO head Tedros hit back at Trump's reasons for the US exit from WHO .
Story with @janicekew:
www.bloomberg.com/news/article...
It comes as WHO head Tedros hit back at Trump's reasons for the US exit from WHO .
Story with @janicekew:
www.bloomberg.com/news/article...
WHO Top Chiefs Hit Back at Trump Over Foreign Aid Orders
The two most senior executives at the World Health Organization have hit back at decisions by President Donald Trump to withdraw from the global health agency and suspend US foreign aid.
www.bloomberg.com
February 3, 2025 at 4:29 PM
The WHO is having to step in to fill gaps left by the US in the latest Ebola outbreak in Uganda, WHO emergencies chief Mike Ryan told Bloomberg.
It comes as WHO head Tedros hit back at Trump's reasons for the US exit from WHO .
Story with @janicekew:
www.bloomberg.com/news/article...
It comes as WHO head Tedros hit back at Trump's reasons for the US exit from WHO .
Story with @janicekew:
www.bloomberg.com/news/article...
Reposted by Ashleigh Furlong
Guessing that consultants such as myself had better start looking elsewhere. Hate the thought that #WHO may have to start making difficult decisions re their priorities
SCOOP: The World Health Organization is freezing hiring, suspending investments and cutting non-essential travel in response to US President Donald Trump’s decision to take the US out of the global body.
News on Bloomberg Terminal. Link to story to come.
News on Bloomberg Terminal. Link to story to come.
January 24, 2025 at 10:33 AM
Guessing that consultants such as myself had better start looking elsewhere. Hate the thought that #WHO may have to start making difficult decisions re their priorities
SCOOP: The World Health Organization is freezing hiring, suspending investments and cutting non-essential travel in response to US President Donald Trump’s decision to take the US out of the global body.
News on Bloomberg Terminal. Link to story to come.
News on Bloomberg Terminal. Link to story to come.
January 24, 2025 at 8:50 AM
SCOOP: The World Health Organization is freezing hiring, suspending investments and cutting non-essential travel in response to US President Donald Trump’s decision to take the US out of the global body.
News on Bloomberg Terminal. Link to story to come.
News on Bloomberg Terminal. Link to story to come.
Reposted by Ashleigh Furlong
🤦🏽♀️It's happening.
✂The US has withdrawn from the WHO.
🕳️The first impact of the withdrawal will be on the staff seconded to the WHO from US agencies.
💯Excellent analysis about the impact of this decision by @ashleighfurlong.bsky.social at @bloombergnews.bsky.social
👇🏼
bit.ly/4hkJYvG
✂The US has withdrawn from the WHO.
🕳️The first impact of the withdrawal will be on the staff seconded to the WHO from US agencies.
💯Excellent analysis about the impact of this decision by @ashleighfurlong.bsky.social at @bloombergnews.bsky.social
👇🏼
bit.ly/4hkJYvG
January 21, 2025 at 4:15 PM
🤦🏽♀️It's happening.
✂The US has withdrawn from the WHO.
🕳️The first impact of the withdrawal will be on the staff seconded to the WHO from US agencies.
💯Excellent analysis about the impact of this decision by @ashleighfurlong.bsky.social at @bloombergnews.bsky.social
👇🏼
bit.ly/4hkJYvG
✂The US has withdrawn from the WHO.
🕳️The first impact of the withdrawal will be on the staff seconded to the WHO from US agencies.
💯Excellent analysis about the impact of this decision by @ashleighfurlong.bsky.social at @bloombergnews.bsky.social
👇🏼
bit.ly/4hkJYvG
The WHO's relationship with China is a key reason for the US exit. That influence could now increase as countries in Asia and the Middle East step into the gap left by the US, Anders Nordström, former acting director-general at the WHO told Bloomberg.
Gift link:
www.bloomberg.com/news/article...
Gift link:
www.bloomberg.com/news/article...
Health Agency Calls on Trump to Reconsider Withdrawal
The World Health Organization called on the US to reconsider President Donald Trump’s decision to exit the agency, suggesting the move could undermine global health security.
www.bloomberg.com
January 21, 2025 at 2:30 PM
The WHO's relationship with China is a key reason for the US exit. That influence could now increase as countries in Asia and the Middle East step into the gap left by the US, Anders Nordström, former acting director-general at the WHO told Bloomberg.
Gift link:
www.bloomberg.com/news/article...
Gift link:
www.bloomberg.com/news/article...
Reposted by Ashleigh Furlong
New paper 📢
The Infected Blood Inquiry (IBI), led by Sir Brian Langstaff, examined one of the UK's largest public health scandals: 30,000 infections & 3,000+ deaths from infected blood products (1970–90s).
Thread below.
The Infected Blood Inquiry (IBI), led by Sir Brian Langstaff, examined one of the UK's largest public health scandals: 30,000 infections & 3,000+ deaths from infected blood products (1970–90s).
Thread below.
December 21, 2024 at 11:34 AM
New paper 📢
The Infected Blood Inquiry (IBI), led by Sir Brian Langstaff, examined one of the UK's largest public health scandals: 30,000 infections & 3,000+ deaths from infected blood products (1970–90s).
Thread below.
The Infected Blood Inquiry (IBI), led by Sir Brian Langstaff, examined one of the UK's largest public health scandals: 30,000 infections & 3,000+ deaths from infected blood products (1970–90s).
Thread below.
I’m a health reporter and I’m looking to speak to patients who have received NHS-funded operations at private hospitals in England. I would love to chat about your experience. DM me or email me at [email protected]
#journorequest #privatehealthcare #NHS
#journorequest #privatehealthcare #NHS
January 3, 2025 at 9:46 AM
I’m a health reporter and I’m looking to speak to patients who have received NHS-funded operations at private hospitals in England. I would love to chat about your experience. DM me or email me at [email protected]
#journorequest #privatehealthcare #NHS
#journorequest #privatehealthcare #NHS
UK cancer patients are being denied access to drugs as the regulator, drugmakers & government stand-off over prices.
A complex and difficult story to write, but one that I think encapsulates the challenges of access to new drugs in the UK. Gift link:
www.bloomberg.com/news/article...
A complex and difficult story to write, but one that I think encapsulates the challenges of access to new drugs in the UK. Gift link:
www.bloomberg.com/news/article...
Cancer Patients in England Denied Access to Drugs Over Price Standoff
The medicines pricing regulator, pharmaceutical companies and government are locked in a row over access to life-extending therapies.
www.bloomberg.com
November 14, 2024 at 7:34 AM
UK cancer patients are being denied access to drugs as the regulator, drugmakers & government stand-off over prices.
A complex and difficult story to write, but one that I think encapsulates the challenges of access to new drugs in the UK. Gift link:
www.bloomberg.com/news/article...
A complex and difficult story to write, but one that I think encapsulates the challenges of access to new drugs in the UK. Gift link:
www.bloomberg.com/news/article...